September 3rd 2024
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
August 23rd 2024
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.
August 22nd 2024
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
August 19th 2024
The First to Know Syphilis Test detects a current or past infection, regardless of successful treatment, in 15 minutes using a drop of blood.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 16, 2021
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 15, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 14, 2021
Persistent Dyspnea in Patients with Long COVID-19 May Indicate Heart Issues
New research presented at EuroEcho 2021 may help explain why some patients with long COVID-19 experience persistent dyspnea even 1 year after recovery.
Flu Responds to COVID-19 Allegations: Press Conference Transcript
Influenza takes questions from key media outlets to rebut assertions by COVID-19 that Flu's heyday has come to an end. He replies to MSNBC, Fox News, CBS, & the Christian Science Monitor.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 9, 2021
Pfizer: Protection Against Omicron Variant ‘Improved’ After 3 Doses of COVID-19 Vaccine
New preliminary laboratory data showed 3 doses of the Pfizer-BioNTech COVID-19 vaccine neutralized the Omicron variant while 2 doses reduced neutralization titers.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 8, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 7, 2021
J&J COVID-19 Booster May Offer More Protection in Mix-and-Match Scenario
A J&J booster shot following a 2-dose regimen of the Pfizer vaccine produced a greater CD8+ T-cell response than a third Pfizer dose, according to preliminary data.
Influenza Virus: How well do you know this enemy?
The flu is well known to all primary care providers - but contributor Terry Brenneman, MD, created 6 questions on topics you might not ordinarily discuss. Quiz time.
Early Increase in Positive Flu Tests Seen Among Young Adults
Pockets of positive tests for influenza A(H3N2), including on college campuses, may herald the opening of the 2021-2022 flu season.
New Analysis Projects Older Ages and Rising Number of Patients with HIV by 2030
Nearly 25% of patients with HIV who use antiretroviral therapy will reach 65 years of age or older by 2030, researchers projected in a new analysis.
NIH Influenza and COVID-19 Guideline Topline: Testing, Treatment, and Vaccination
The influenza and SARS-CoV-2 viruses once again are in cocirculation. Following is a topline look at the NIH guideline on their simultaneous management.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 1, 2021
FDA Advisory Committee Narrowly Backs Merck’s Oral COVID-19 Antiviral
The 13-10 vote was not without controversy as panel members discussed concerns over the novel antiviral's safety risks and modest efficacy.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 30, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 23, 2021
COVID-19 Cases, Hospitalizations Up: Top 5 States Reporting Increases
COVID-19 cases are up by double digits in many states and hospitalizations have made big leaps in others. We report the top 5 in each category for the 7 days from 11/14-21.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 22, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 19, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 16, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 15, 2021
Pfizer Submits Request to Expand COVID-19 Booster EUA to All US Adults
Pfizer-BioNTech included data in its FDA submission showing the 3rd mRNA shot restores protection against symptomatic COVDI-19 to about 95%.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 10, 2021
Living in More Socially Vulnerable Neighborhood Linked to Worse Outcomes in Hospitalized COVID-19 Patients
AHA Scientific Sessions 2021: New research found living in socially vulnerable neighborhoods increased the risk of myocardial infarction, stroke, or death among hospitalized COVID-19 patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 9, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 8, 2021
Effectiveness Declines for All 3 COVID-19 Vaccines Over Time in Large Veterans Study
Efficacy of COVID-19 vaccines from Pfizer, Moderna, and J&J fell between 35% and 85% among nearly 800 000 US veterans, found a consortium of investigators.
Pfizer Announces Novel Oral COVID-19 Antiviral Cuts Risk of Hospitalization, Death by 89% in High-risk Adults
The Pfizer study was stopped early for efficacy and the company plans to submit data to the US FDA for Emergency Use Authorization as soon as possible, according to a statement.